Afatinib-d6 is the d6 labelled analogue of Afatinib (A355300) which is an aminocrotonylamino-substituted quinazoline derivative used for treating cancer and diseases of the respiratory tract, lungs, gastrointestinal tract, bile duct, and gallbladder.
